Society guideline links: COVID-19 – Dermatology care

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)

International

●International Eczema Council (IEC): Statement on COVID-19

●International Psoriasis Council (IPC): Revised statement on COVID-19 (2022)

United States

●American Academy of Dermatology (AAD): Guidance on the use of immunosuppressive agents

●AAD: Running your dermatology practice during COVID-19

●The Society for Pediatric Dermatology (SPD): Management of infantile hemangiomas during the COVID-19 pandemic

●American Society for Dermatologic Surgery (ASDS) and American Society for Laser Medicine & Surgery (ASLMS): Guidance for cosmetic dermatology practices during COVID-19 (2021)

●National Psoriasis Foundation (NPF): Guidance for management of psoriatic disease during the pandemic – Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments, version 2 (2021)

●ASDS: Guidance regarding SARS-CoV-2 mRNA vaccine side effects in dermal filler patients (2020)

●Wound, Ostomy, and Continence Nurses Society (WOCN): Guidance for maintaining skin health when utilizing protective masks for prolonged time intervals (2020)

Europe

●European Reference Networks (ERN): Patients with rare skin diseases and COVID-19 virus

●European Task Force on Atopic Dermatitis (ETFAD): Position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics (2021)

●European Academy of Dermatology and Venerology (EADV): Position statement on quality of life issues in dermatologic patients during the COVID-19 pandemic (2020)

●ETFAD: Statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and atopic dermatitis (2020)

United Kingdom

●British Association of Dermatologists (BAD): Dermatology advice regarding self-isolation and immunosuppressed patients – Adults, paediatrics and young people

●British Photodermatology Group (BPG): Statement on reintroducing photodiagnostic services during the recovery period of the SARS-CoV-2 pandemic (2021)

●BPG: Statement on reintroducing photodynamic therapy during the recovery period of the SARS-CoV-2 pandemic (2021)

●BPG: Statement regarding phototherapy services during the recovery period of the SARS-CoV-2 pandemic (2021)

●British Society for Cutaneous Allergy (BSCA) and BAD: Statement regarding resuming patch testing during and post the coronavirus pandemic (2020, updated 2021)

●British Society for Paediatric Dermatology (BSPD): Guidance on how to recommence paediatric dermatology services (2020, updated 2021)

●BAD: COVID-19 – Clinical guidelines for the management of dermatology patents remotely (2020)

●BAD: COVID-19 – Phase 2 recommencing services, diagnoses and interventions for major & common skin disorders (2020)

●BAD: Guidance for managing patients on isotretinoin during the coronavirus pandemic (2020)

●BAD: Guidance for managing urticaria patients on omalizumab during the coronavirus pandemic (2020)

●BAD and British Society for Dermatological Surgery (BSDS): Clinical guidance for the management of skin cancer patients during the coronavirus pandemic (updated 2020)

●BAD and BSDS: COVID-19 – Recommencing skin cancer surgery services during the coronavirus pandemic (2020)

●Royal College of Radiologists (RCR): Non-melanoma skin cancer management and COVID-19 pandemic, update (2020)

India

●Indian Association of Dermatologists, Venereologists and Leprologists (IADVL): Position statement and recommendations on post lockdown dermatology practice amidst the COVID-19 pandemic (2020)

Australia–New Zealand

●COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease – An Australia/New Zealand consensus statement (2020)

Resources for patients — The following links provide resources about COVID-19 for non-clinicians. These resources come from select society and government-sponsored guidelines from several countries and regions around the world.

●[International] International Federation of Psoriasis Associations (IFPA): Global advice – Psoriasis and COVID-19

●[United States] American Academy of Dermatology (AAD): Coronavirus resource center

●[United States] American Society for Dermatologic Surgery (ASDS): COVID-19 patient education resources

●[United States] National Eczema Association (NEA): Ask the Ecz-perts – Coronavirus (COVID-19)

●[United States] National Psoriasis Foundation (NPF): COVID-19 resource center

UpToDate also offers "The Basics" patient education pieces, which are written by the doctors and editors at UpToDate. These are written in plain language, at the 5^th to 6^th grade reading level, and answer the main questions a person is likely to have. (See "Patient education: COVID-19 overview (The Basics)" and "Patient education: COVID-19 and children (The Basics)" and "Patient education: COVID-19 and pregnancy (The Basics)" and "Patient education: COVID-19 vaccines (The Basics)".)